The transparency of the program is also critical
Tirzepatide may also be prescribed among individuals who are overweight, with a BMI of 27 or higher, if they have other health issues that are associated with their being overweight
ii) clinical (acne, hirsutism) or biochemical signs of hyperandrogenism
( Epub ahead of print ) Colmenero I, Santonja C, Alonso-Riao M, Noguera-Morel L, Hernndez-Martn A, Andina D et al (2020) SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases
This trial was funded by Eli Lilly, the manufacturer of Zepbound (tirzepatide), which participated in the data collection and analysis, although the article was written by the academic researchers